Alzai Health Corp. ALZIF
OTC PK
| 04/30/2026 | 01/31/2026 | 10/31/2025 | 07/31/2025 | ||
|---|---|---|---|---|---|
| Revenue | 0.00 | 19.90K | -- | -- | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | 0.00 | 19.90K | -- | -- | |
| Cost of Revenue | 103.30K | 70.10K | 107.90K | 20.90K | |
| Gross Profit | -103.30K | -50.20K | -107.90K | -20.90K | |
| SG&A Expenses | 182.50K | 645.10K | 434.00K | 265.40K | |
| Depreciation & Amortization | 3.60K | 3.20K | 2.60K | 2.60K | |
| Other Operating Expenses | -- | -- | -- | -- | |
| Total Operating Expenses | 491.90K | 1.11M | 658.90K | 408.60K | |
| Operating Income | -491.90K | -1.09M | -658.90K | -408.60K | |
| Income Before Tax | -536.40K | -1.08M | -674.80K | -392.60K | |
| Income Tax Expenses | -- | -- | -- | -- | |
| Earnings from Continuing Operations | -536.40K | -1.08M | -674.80K | -392.60K | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | -536.40K | -1.08M | -674.80K | -392.60K | |
| EBIT | -491.90K | -1.09M | -658.90K | -408.60K | |
| EBITDA | -490.90K | -1.09M | -658.90K | -407.30K | |
| EPS Basic | -0.01 | -0.02 | -0.01 | -0.01 | |
| Normalized Basic EPS | -0.01 | -0.01 | -0.01 | -0.01 | |
| EPS Diluted | -0.01 | -0.02 | -0.01 | -0.01 | |
| Normalized Diluted EPS | -0.01 | -0.01 | -0.01 | -0.01 | |
| Average Basic Shares Outstanding | 53.32M | 53.09M | 51.43M | 47.62M | |
| Average Diluted Shares Outstanding | 53.32M | 53.09M | 51.43M | 47.62M | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |